First European launch in Denmark of Brintellix for Major Depressive Episodes- Lundbeck.

H. Lundbeck A/S has now started the launch of its novel antidepressant Brintellix (vortioxetine) in Denmark. This marks the first European launch and thereby the next step in the global introduction of Brintellix, which was commercially launched in the US in January 2014. Following the Danish launch, Brintellix, which is approved for treatment of major depressive episodes in adults, will be introduced in several other European and International Markets during 2014 and 2015